Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Active and Healthy Brotherhood: A Program for Chronic Disease Self-Management for Black Men

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02362737
Recruitment Status : Active, not recruiting
First Posted : February 13, 2015
Last Update Posted : August 3, 2017
Sponsor:
Collaborators:
Patient-Centered Outcomes Research Institute
Arizona State University
Project Brotherhood
University of North Carolina, Chapel Hill
Vanderbilt University
Information provided by (Responsible Party):
Gramercy Research Group

Brief Summary:
This study will test ways to improve health behaviors using an intervention that has been specially designed for African-American men. The program, called Active & Healthy Brotherhood (AHB), will provide information on basic health, and healthy eating, physical activity, stress management, and how to get medical care when needed.The AHB intervention will be compared to a control group that will receive basic health information in videos and brochures.

Condition or disease Intervention/treatment Phase
Chronic Disease Obesity Hypertension Diabetes Self Care Medication Adherence Behavioral: Active and Healthy Brotherhood (AHB) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 332 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Study Start Date : January 2015
Actual Primary Completion Date : July 2017
Estimated Study Completion Date : June 30, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Active and Healthy Brotherhood (AHB)
16-week behavioral intervention
Behavioral: Active and Healthy Brotherhood (AHB)
Participants will attend group sessions led by trained group facilitators. The group sessions will be ~16 weekly meetings of ~90 minutes duration for 4 months. AHB participants will also engage in experiential learning opportunities. Following the intensive intervention phase, during months 5 and 6, participants will receive three structured, individual phone calls with the group facilitator.

No Intervention: Control
Usual care.



Primary Outcome Measures :
  1. Change activity behavior (minutes per week in Total physical activity (PA) and light, moderate, vigorous PA). [ Time Frame: baseline, 6 months, 12 months ]
    Minutes per week in Total physical activity (PA) and light, moderate, vigorous PA

  2. Change sedentary behavior (minutes per week of sedentary behavior). [ Time Frame: baseline, 6 months, 12 months ]
    Minutes per week of sedentary behavior

  3. Change dietary intake (Fruit and vegetable servings, % fat, sodium and fiber intake). [ Time Frame: baseline, 6 months, 12 months ]
    Fruit and vegetable servings, % fat, sodium and fiber intake

  4. Change stress management. [ Time Frame: baseline, 6 months, 12 months ]
    Identification of issues and strategies that affect stress management

  5. Change help-seeking behaviors (Medication adherence and doctor/ER visits). [ Time Frame: baseline, 6 months, 12 months ]
    Medication adherence and doctor/ER visits


Secondary Outcome Measures :
  1. Change blood pressure. [ Time Frame: baseline, 6 months, 12 months ]
  2. Change body weight. [ Time Frame: baseline, 6 months, 12 months ]
  3. Change blood glucose. [ Time Frame: baseline, 6 months, 12 months ]
  4. Change HbA1c. [ Time Frame: baseline, 6 months, 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 64 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. AA (based on self-report)
  2. self-reported male
  3. aged at least 21 years
  4. non-institutionalized (i.e., community-dwelling, not living in assisted living facilities, nursing homes, etc.)
  5. at high risk for developing chronic disease (e.g., not meeting current guidelines for PA and/or F&V intake; current smoker; diagnosed with high cholesterol) or
  6. currently diagnosed with diabetes, hypertension, or cardiovascular disease
  7. residents of Forsyth County, NC (or surrounding areas and able to attend group sessions in Forsyth County).

Exclusion Criteria:

  1. have had a cardiovascular procedure (e.g., heart surgery), heart attack, heart failure, stroke in the last 6 months
  2. have cognitive, visual, auditory, physical functional (e.g., unable to walk unassisted), or language impairment precluding participation in group discussion, learning activities, or data collection.
  3. currently achieve >150 min/wk of moderate intensity PA or >75 min/wk of vigorous intensity PA AND currently consume > 9 servings of F&V daily.
  4. are currently enrolled in a chronic disease management program.
  5. are unwilling to accept randomization assignment or planning to move from local area in <2 years.
  6. are currently receiving chemotherapy/radiation treatments.

Participants will be required to obtain approval from a health care provider prior to participation in the study if they:

  1. are unable to participate in moderate PA due to physical limitations as indicated by positive (risk) responses on the PA Readiness Questionnaire (PAR-Q) and/or physician disapproval on the PAR Medical Examination.
  2. have BP>180/>110 and/or HbA1C>12 and/or triglycerides >500.
  3. have health conditions that could preclude changes to diet (e.g., irritable bowel syndrome, celiac disease)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02362737


Locations
Layout table for location information
United States, North Carolina
Gramercy Research Group
Winston-Salem, North Carolina, United States, 27106
Sponsors and Collaborators
Gramercy Research Group
Patient-Centered Outcomes Research Institute
Arizona State University
Project Brotherhood
University of North Carolina, Chapel Hill
Vanderbilt University

Layout table for additonal information
Responsible Party: Gramercy Research Group
ClinicalTrials.gov Identifier: NCT02362737     History of Changes
Other Study ID Numbers: AD-1403-11098
First Posted: February 13, 2015    Key Record Dates
Last Update Posted: August 3, 2017
Last Verified: August 2017

Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Disease
Disease Attributes
Pathologic Processes